IDP4SCLC Drug optimization of new therapeutic targets IDP (ASCL1) for the treatment of small cell lung cancer
- Reference: RTC-2017-6585-1
- Duration: 2 years
- Start date: 1 de january de 2018
- End date: 31 de december de 2020
- Funded by: FEDER/Ministry of Science, Innovation and Universities - State Research Agency
- Grant: 168,654.40€
- Type: Nacional
Need more information?
If you are interested in learning more about our research, please contact us.